Parabiosis, Assembloids, Organoids (PAO).

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Disease Modeling

Background:

• Current disease models (2D cultures, animal models) have significant limitations in replicating human physiology and multi-organ interactions.
• Parabiosis offers insights into systemic factors but has limited human applicability; organoids model individual tissues but not inter-tissue dynamics.
• Complex human diseases require sophisticated models that capture systemic regulation and multi-organ crosstalk.

Purpose of the Study:

• To review the development and limitations of parabiosis, organoids, and assembloids (PAO models).
• To highlight the transformative potential of integrating PAO models with emerging biomedical engineering technologies.
• To explore advancements in disease modeling, regenerative medicine, and precision therapeutics.

Main Methods:

• Review of existing literature on parabiosis, organoids, and assembloids.
• Evaluation of the integration of PAO models with AI, CRISPR, organ-on-a-chip, and soft robotics.
• Analysis of the potential of these integrated approaches for studying complex diseases.

Main Results:

• PAO models, particularly assembloids, overcome limitations of individual approaches by enabling multi-organ interaction simulation.
• Integration with technologies like AI and CRISPR enhances disease mechanism elucidation and precision analytics.
• Combined approaches show promise for revolutionizing disease modeling and therapeutic development.

Conclusions:

• Parabiosis, organoids, and assembloids represent a significant advancement in disease modeling.
• The synergy between PAO models and frontier biomedical engineering technologies is key to addressing complex human diseases.
• These integrated models pave the way for breakthroughs in regenerative medicine and precision therapeutics.